Business Description
PureTech Health PLC
NAICS : 325412
SIC : 2834
ISIN : GB00BY2Z0H74
Description
PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Wholly-Owned Programs, Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 20.9 | |||||
| Equity-to-Asset | 0.55 | |||||
| Debt-to-Equity | 0.08 | |||||
| Debt-to-EBITDA | -0.45 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 1.69 | |||||
| Beneish M-Score | -3.19 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -54.3 | |||||
| 3-Year EPS without NRI Growth Rate | -13.5 | |||||
| 3-Year FCF Growth Rate | 4.5 | |||||
| 3-Year Book Growth Rate | -8.2 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 164.84 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 38.82 | |||||
| 9-Day RSI | 40.92 | |||||
| 14-Day RSI | 38.51 | |||||
| 3-1 Month Momentum % | -17.82 | |||||
| 6-1 Month Momentum % | -24.55 | |||||
| 12-1 Month Momentum % | -37.12 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.68 | |||||
| Quick Ratio | 3.68 | |||||
| Cash Ratio | 3.63 | |||||
| Days Sales Outstanding | 3576.14 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 1.7 | |||||
| Shareholder Yield % | 29.69 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -19477.07 | |||||
| Net Margin % | -8752.28 | |||||
| FCF Margin % | -16129.73 | |||||
| ROE % | -19.08 | |||||
| ROA % | -12.55 | |||||
| ROIC % | -51.61 | |||||
| 3-Year ROIIC % | 76.56 | |||||
| ROC (Joel Greenblatt) % | -294.61 | |||||
| ROCE % | -9.92 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 67.68 | |||||
| PS Ratio | 721 | |||||
| PB Ratio | 1.39 | |||||
| Price-to-Tangible-Book | 1.4 | |||||
| EV-to-EBIT | 0.93 | |||||
| EV-to-EBITDA | 0.99 | |||||
| EV-to-Forward-EBITDA | -0.06 | |||||
| EV-to-Revenue | -70.5 | |||||
| EV-to-FCF | 0.44 | |||||
| Price-to-GF-Value | 5.61 | |||||
| Price-to-Net-Current-Asset-Value | 1.79 | |||||
| Price-to-Net-Cash | 1.85 | |||||
| Earnings Yield (Greenblatt) % | 107.53 | |||||
| FCF Yield % | -27.59 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:PTCHF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PureTech Health PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.75 | ||
| EPS (TTM) ($) | -0.3 | ||
| Beta | 0.91 | ||
| 3-Year Sharpe Ratio | -0.44 | ||
| 3-Year Sortino Ratio | -0.63 | ||
| Volatility % | 30.25 | ||
| 14-Day RSI | 38.51 | ||
| 14-Day ATR ($) | 0.008977 | ||
| 20-Day SMA ($) | 1.7628 | ||
| 12-1 Month Momentum % | -37.12 | ||
| 52-Week Range ($) | 1.66 - 3 | ||
| Shares Outstanding (Mil) | 239.42 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PureTech Health PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PureTech Health PLC Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
PureTech Health PLC Frequently Asked Questions
What is PureTech Health PLC(PTCHF)'s stock price today?
The current price of PTCHF is $1.74. The 52 week high of PTCHF is $3.00 and 52 week low is $1.66.
When is next earnings date of PureTech Health PLC(PTCHF)?
The next earnings date of PureTech Health PLC(PTCHF) is 2025-04-25 Est..
Does PureTech Health PLC(PTCHF) pay dividends? If so, how much?
PureTech Health PLC(PTCHF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers